Schedule of Redeemable Noncontrolling Interest |
A summary of the Company’s redeemable noncontrolling interests on its consolidated balance sheets is set forth below: | | | | | | | | | | | | | | | | | | | | | | | | | At December 31, | 2023 | | 2022 | | | Redeemable noncontrolling interest - DaVinci | $ | 2,541,482 | | | $ | 1,740,300 | | | | Redeemable noncontrolling interest - Medici | 1,650,229 | | | 1,036,218 | | | | Redeemable noncontrolling interest - Vermeer | 1,555,297 | | | 1,490,840 | | | | Redeemable noncontrolling interest - Fontana | 353,823 | | | 268,031 | | | | Redeemable noncontrolling interests | $ | 6,100,831 | | | $ | 4,535,389 | | | | | | | | |
A summary of the Company’s redeemable noncontrolling interests on its consolidated statements of operations is set forth below: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Year ended December 31, | 2023 | | 2022 | | 2021 | | | Redeemable noncontrolling interest - DaVinci | $ | 545,812 | | | $ | (65,514) | | | $ | (102,932) | | | | Redeemable noncontrolling interest - Medici | 239,250 | | | (70,504) | | | 1,492 | | | | Redeemable noncontrolling interest - Vermeer | 239,457 | | | 43,058 | | | 38,155 | | | | Redeemable noncontrolling interest - Fontana | 34,476 | | | (5,653) | | | — | | | | Net income (loss) attributable to redeemable noncontrolling interests | $ | 1,058,995 | | | $ | (98,613) | | | $ | (63,285) | | | | | | | | | | |
The activity in redeemable noncontrolling interest – DaVinci is detailed in the table below: | | | | | | | | | | | | | | | | | | | | | | | | | Year ended December 31, | 2023 | | 2022 | | | Beginning balance | $ | 1,740,300 | | | $ | 1,499,451 | | | | Redemption of shares from redeemable noncontrolling interests | (123,272) | | | (161,570) | | | | Sale of shares to redeemable noncontrolling interests, net of adjustments | 378,642 | | | 467,933 | | | | | | | | | | Net income (loss) attributable to redeemable noncontrolling interest | 545,812 | | | (65,514) | | | | | | | | | | Ending balance | $ | 2,541,482 | | | $ | 1,740,300 | | | | | | | | |
The activity in redeemable noncontrolling interest – Medici is detailed in the table below: | | | | | | | | | | | | | | | | | | | | | | | | | Year ended December 31, | 2023 | | 2022 | | | Beginning balance | $ | 1,036,218 | | | $ | 856,820 | | | | Redemption of shares from redeemable noncontrolling interests | (107,549) | | | (100,234) | | | | Sale of shares to redeemable noncontrolling interests | 482,310 | | | 350,136 | | | | Net income (loss) attributable to redeemable noncontrolling interest | 239,250 | | | (70,504) | | | | | | | | | | | | | | | | Ending balance | $ | 1,650,229 | | | $ | 1,036,218 | | | | | | | | |
The activity in redeemable noncontrolling interest – Vermeer is detailed in the table below: | | | | | | | | | | | | | | | | | | | | | | | | | Year ended December 31, | 2023 | | 2022 | | | Beginning balance | $ | 1,490,840 | | | $ | 1,197,782 | | | | Redemption of shares from redeemable noncontrolling interest | (175,000) | | | — | | | | Sale of shares to redeemable noncontrolling interest | — | | | 250,000 | | | | | | | | | | Net income (loss) attributable to redeemable noncontrolling interest | 239,457 | | | 43,058 | | | | | | | | | | Ending balance | $ | 1,555,297 | | | $ | 1,490,840 | | | | | | | | |
The activity in redeemable noncontrolling interest – Fontana is detailed in the table below: | | | | | | | | | | | | | | | | | | | | | | | | | Year ended December 31, | 2023 | | 2022 | | | Beginning balance | $ | 268,031 | | | $ | — | | | | | | | | | | Sale of shares to redeemable noncontrolling interest | 51,316 | | | 273,684 | | | | | | | | | | Net income (loss) attributable to redeemable noncontrolling interest | 34,476 | | | (5,653) | | | | | | | | | | Ending balance | $ | 353,823 | | | $ | 268,031 | | | | | | | | |
|